glp 1 is it a hormone Sister of GLP-1 could lead to better weight-loss drugs GLP-1 Agonists - What is

A master protocol for orforglipron (LY3502970) in participants with hypertension and obesity or overweight: (ATTAIN-Hypertension screening)

GLP-1 RA use in type 1 diabetes has been associated with an increased risk of symptomatic and asymptomatic hypoglycaemia [45]

Rare sugar syrup containing D-allulose but not high-fructose corn syrup maintains glucose homeostasis and hepatic gene expression in wistar rats

Tirzepatide can cause rapid fat mobilization, and the lipotropic agents in Lipo C, like choline and methionine, are thought to help the liver process this increased fatty acid load more efficiently, potentially reducing hepatic stress

In the absence of such a marker, there is value to understand what (if any) clinical factors are associated with increased risk of PDAC amongst those who are using GLP-1RAs